Digital Tablet-Based Testings for the Screening of Neurocognitive Disorders in Older Adults: a Diagnosis Study. (Preprint)
Authors:
- Nathavy Um DinNDNathavy Um Din
- Florian MaronnatFMFlorian Maronnat
- Sylvie ParielSPSylvie Pariel
- Quentin Le BoterffQBQuentin Le Boterff
- Maxime TeremetzMTMaxime Teremetz
- Fadi BadraFBFadi Badra
- Påvel G. LindbergPLPåvel G. Lindberg
- Frédéric DavesneFDFrédéric Davesne
- Guillaume LoupGLGuillaume Loup
- Samir OtmaneSOSamir Otmane
- Joël BelminJoël Belmin
Preprint
- 15 November 2026
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND The prevalence of neurocognitive disorders (NCD) is increasing as the population ages. The diagnosis includes a time-consuming medical and neuropsychological battery of tests in specialized centers. The development of effective screening tools could benefit primary care professionals by improving referral practices. OBJECTIVE To explore the feasibility of a digital tablet-based investigation comprising a wide set of questions combined with cognitive and manual dexterity tasks, study their relevance for the diagnosis of NCD, and select the best combination of variables likely to help the screening. METHODS We conducted a prospective diagnosis study conducted in 2 memory clinics. We recruited older adults who underwent a comprehensive cognitive assessment with a specialized team leading to a reference diagnostic. This consisted in 3-category classification: no NCD, mild NCD (m-NCD) and major NCD (M-NCD). At the same time, they completed a variety of testings implemented on a touchscreen tablet which included a medical questionnaire, cognitive and manual dexterity tasks. We analyzed the dataset using several approaches to determine the most important variables for identifying M-NCD, or any NCD (either m-NCD or M-NCD). RESULTS We included 160 participants whose reference diagnosis were M-NCD for 58 of them, m-NCD for 52, and no NCD for 50. The feasibility of the index test battery was excellent; all participants answered the medical questionnaire, all completed the cognitive tasks, and there were 7 protocol stops during the manual dexterity tasks due to pain and poor hand detection. We achieved a final model with 9 variables for the detection of M-NCD and 5 for any NCD. The variables relevant for identifying M-NCD are those related to loss of independence, frailty, information processing, sleep, and executive functions related to manual dexterity (inhibition and mental flexibility). Sensitivity was 81% and specificity 86%, with an AUC of 0.90 for the screening of M-NCD. The variables relevant to identifying NCD are memory, categorization, processing speed, the presence of hypertension, and success in a motor task requiring mental flexibility. Sensitivity was 81% and specificity 82% with and AUC of 0.91 for the detection of any NCD. CONCLUSIONS We identified 2 combinations of variables that can distinguish any NCD from M-NCD with satisfactory performance for a screening. CLINICALTRIAL This study has been registered in clinical trial under the number NCT06032611. The protocol has been approved by the French national ethic committee (Comité de Protection des Personnes Est III) under the number IDRCB2022-A00609-34.This publication has 41 references indexed in Scilit:
- Distinct trajectories of subjective cognitive decline before diagnosis of neurocognitive disorders: Longitudinal modelling over 18 yearsThe Journal Of Prevention of Alzheimer's Disease, 2025
- MemScreen: A smartphone application for detection of mild cognitive impairment: A validation studyThe Journal Of Prevention of Alzheimer's Disease, 2025
- Alzheimer Disease as a Clinical-Biological Construct—An International Working Group RecommendationJAMA Neurology, 2024
- Usability of the digit-tracking technique in a geriatric population of inpatients with and without neurocognitive disorders: The DIGICOG-start studyJournal of Neural Transmission, 2024
- Dementia prevention, intervention, and care: 2024 report of the Lancet standing CommissionThe Lancet, 2024
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Rethinking the detection and diagnosis of Alzheimer’s disease: Outcomes of a European Brain Council projectAging Brain, 2023
- Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer’s Disease (AD) in the elderly?International Psychogeriatrics, 2019
- The cognitive disorders examination (Codex) is a reliable 3-minute test for detection of dementia in the elderly (validation study on 323 subjects)La Presse Médicale, 2007
- Ceftriaxone et autres infections : maladie de lyme, M.S.T.Medecine Et Maladies Infectieuses, 1989